Human in vivo assessment of ketamine binding of the serotonin transporter—follow up at a higher dose

Authors

Gerhard Schlosser (ORCID: https://orcid.org/0000-0002-1300-1331)
M. Hacker
Rupert R. Lanzenberger (ORCID: https://orcid.org/0000-0003-4641-9539)
Matej Murgaš (ORCID: https://orcid.org/0000-0001-7643-2182)
Dan Rujescu (ORCID: https://orcid.org/0000-0002-1432-313X)
Siegfried Kasper (ORCID: https://orcid.org/0000-0001-8278-191X)
Sabine Reichel
L. Silberbauer (ORCID: https://orcid.org/0000-0002-8521-1012)
Godber Mathis Godbersen (ORCID: https://orcid.org/0000-0002-9739-0724)
Marie Spies (ORCID: https://orcid.org/0000-0002-9963-9044)
Dietmar Winkler (ORCID: https://orcid.org/0000-0001-8849-9907)
Thomas Stimpfl (ORCID: https://orcid.org/0000-0003-0418-1809)
Lukas Nics

Institutions

Comprehensive Cancer Center Vienna (AT)
Medical University of Vienna (AT)

Publication Details

Journal: Frontiers in Neuroscience
Published: 2025-10-02
DOI: https://doi.org/10.3389/fnins.2025.1651016
Primary Topic: Treatment of Major Depression
Type: article
Field-Weighted Citation Impact: 0.00

Funders

National Alliance for Research on Schizophrenia and Depression
Austrian Science Fund

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Human in vivo assessment of ketamine binding of the serotonin transporter—follow up at a higher dose

Gerhard Schlosser, M. Hacker, Rupert R. Lanzenberger, Matej Murgaš et al.

Oct 2, 2025

Frontiers in Neuroscience

Treatment of Major Depression

article

Human in vivo assessment of ketamine binding of the serotonin transporter—follow up at a higher dose

Gerhard Schlosser, M. Hacker, Rupert R. Lanzenberger, Matej Murgaš, Dan Rujescu, Siegfried Kasper, Sabine Reichel, L. Silberbauer, Godber Mathis Godbersen, Marie Spies, Dietmar Winkler, Thomas Stimpfl, Lukas Nics

October 2, 2025article en

Abstract

No abstract available for this paper.

Frontiers in NeuroscienceVol. 19

Comprehensive Cancer Center Vienna (AT), Medical University of Vienna (AT)

National Alliance for Research on Schizophrenia and Depression, Austrian Science Fund

Openalex Percentile: Top 69%

Treatment of Major Depression

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.